Beverly Hills, CA (PRWEB) December 05, 2012
There’s a monster hiding under the beds of many diabetes patients, in the form of diabetic neuropathy that can bring on intense pain and numbness at night. Roughly half of all diabetics develop this debilitating complication of the disease. Symptoms include numbness, tingling, burning and stabbing pains that typically worsen at night. Using a revolutionary treatment, The Releford Foot and Ankle Institute can get rid of the chronic symptoms suffered by patients with diabetic neuropathy—for good.
The Releford Foot and Ankle Institute now offers platelet-rich plasma therapy (PRP), an innovative way to treat diabetic neuropathy. Using PRP, a concentrated amount of a patient’s own blood platelets is injected into damaged tissue, supercharging the healing process of damaged nerves from diabetes. The unique protocol and comprehensive therapy also includes dietary and physical activity evaluation.
Says Dr. Bill Releford, Director of The Releford Foot and Ankle Institute, “Not only can the intense pain of diabetic neuropathy keep patients awake at night, the numbness can also affect their balance and ability to walk, creating a danger of falling. With therapeutic PRP injections, we can manage diabetic neuropathy, with most patients reporting significant, if not complete, relief from in its symptoms.”
About Platelet-Rich Plasma Therapy
PRP therapy is an innovative, non-surgical approach that uses healing components derived from a small, concentrated amount of a patient’s own blood. Injected into damaged tissue, PRP therapy has the potential to “supercharge” the healing process. PRP has been successfully used in orthopedics and sports medicine to treat joint and tendon pain, ankle sprains, heel pain, non-healing wounds, plantar fasciitis, poor circulation, diabetic neuropathy, and many other conditions, as cited in the Journal of Orthopaedic Research (Jan. 2006). Recently, PRP therapy has made headlines due to its successful use by professional athletes like Tiger Woods, Kobe Bryant, Alex Rodriguez, and Rafael Nadal.
About Dr. Bill J. Releford, D.P.M.
Dr. Bill J. Releford, D.P.M., a graduate of the Temple School of Podiatric Medicine in Philadelphia, began his practice in 1990 and established the Diabetic Foot Institute, a facility dedicated exclusively to the reduction of diabetes-related amputations in high-risk populations. Dr. Releford is recognized both domestically and internationally as a leader in the field of diabetic limb preservation and wound care, and recently received prestigious awards from the Association of Black Cardiologists and the Regional Black Chamber of Commerce for his contributions to public health. Dr. Releford uses Platelet-Rich Plasma Therapy to treat diabetic neuropathy, foot injuries and chronic non-healing wounds.
Dr. Releford is an assistant professor at Charles R. Drew University and lectures worldwide about the latest techniques in limb salvage and community-based outreach. He authored the book “Five Colors A Day to Better Health,” and has been featured on “NBC Nightly News” with Brian Williams, ABC’s “The View,” and in The Washington Post, Newsweek, and The Los Angeles Times.
About The Releford Foot and Ankle Institute
The Releford Foot & Ankle Institute’s mission is to effectively decrease the diabetes-related amputation rate in Los Angeles and surrounding communities by providing comprehensive wound care and limb salvage services.
Dr. Releford’s community outreach and health-care advocacy efforts are facilitated through the Diabetic Amputation Prevention Foundation (DAP), a non-profit organization he founded in 2001. Its mission is to educate at-risk populations to better understand diabetes and its complications through community-based programs.
Dr. Releford and the DAP Foundation have been recognized for the success of the Black Barbershop Health Outreach Program. Since its inception in December 2007, the program has screened over 30,000 men for diabetes and hypertension in more than 650 black-owned barbershops in over 42 cities.
For a free consultation and insurance verification, contact the Institute at 310-412-0183.